Find clinical trials for Lung Cancer in Montréal, QC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near Montréal, QC, CAN:
with immunotherapy in patients with metastatic non-small cell lung cancer (NSCLC) resistant to immune checkpoint inhibitors. The pr...
Phase 1
Montreal, Quebec, Canada
The purpose of this study is to find out how many people with HER2-amplified or HER2-mutated non-small cell lung cancer (NSCLC) exp....
Phase 2
Montreal, Quebec, Canada and 9 other locations
a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...
Phase 2
Montreal, Canada and 71 other locations
to docetaxel in participants with advanced non-small cell lung cancer (NSCLC) harboring a KRAS G12C mutation who have been previous...
Phase 3
Montreal, Quebec, Canada and 50 other locations
The standard or usual treatment for this disease is pembrolizumab given by needle into the veins (IV).Some cancers shed DNA (circulating tum...
Phase 2, Phase 3
Montreal, Quebec, Canada and 10 other locations
with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....
Phase 3
Montreal, Quebec, Canada and 210 other locations
resectable, early-stage non-small cell lung cancer....
Phase 2
Montreal, Quebec, Canada and 95 other locations
KRAS G12C inhibitors (sotorasib or adagrasib) in participants with KRAS G12C-positive (KRAS G12C +) advanced or metastatic non-small cell lung...
Phase 3
Montreal, Quebec, Canada and 156 other locations
agent and in combination with pembrolizumab and BBO-10203 in subjects with locally advanced and unresectable or metastatic non-small cell lung...
Phase 1
Montreal, Quebec, Canada and 34 other locations
This is a Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as...
Phase 3
Montreal, Quebec, Canada and 182 other locations
Clinical trials
Research sites
Resources
Legal